The next generation INS approved by Health Canada reduces how frequently a patient needs to recharge their implanted device to once a month for about one hour.
Data show patients implanted with the Axonics r-SNM System receive significant improvements in urinary urgency incontinence symptoms and quality of life.
The patents issued range in subject matter and include coverage of the Axonics clinician programmer, patient remote control, and internal system electronics.